 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Eske Corporation Sac |
| Street 1: | Calle Victor Mantilla 237 |
| Street 2: | |
| City: | Lima |
| Province: | Lima |
| Post Code: | L34 |
| Country: | Peru |
| Phone: | 512413112 ext 141 |
| Organization Email: | patricia.wong@eskegroup.com |
| Web Site: | http://www.eskegroup.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Health |
| Organization Description: | |
| and branded products available in eight countries. We currently have an additional 109 products in the pipeline awaiting approval for release to health care professionals. ESKE products are available in the following therapeutic areas: Anaesthesiology Anthelminthics Anti TB TB Diagnosis products TB research at the genetic and micromolecular level |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 100 + |
| Number of volunteers who are directly involved with TB: | 100 + |
| How did you hear about the Stop TB Partnership: | World TB Day |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | Peru |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| ESKE’s strength lies in our deep commitment to providing the highest quality ant TB we are the major TB drugs rovider for the gobernement we have been supporting many GF programs also we are part of teh National Comitee figthing agains TB. Our TB research department is dedicated to ensuring the most qualified methods to collect data about XDR am MDR TB we are very proud to have Dr. Selene Manga as the most recognized TB specialist as part of our TB research team In addition to offering a wide selection of TB generic products, ESKE markets and distributes branded formulations for TB at the the private health sector and has several category leaders in this area. |
|
Geographical Reach | |
| Which country is your headquarters located in: | Peru |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
El Salvador Honduras Mexico Panama Paraguay Peru Venezuela |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: Fifteen years’ experience as research center for resistant TB TB managing Clinical Trial research, as well as field interventions in DR TB New Diagnostics: As an international company, ESKE is aware of the importance of creating new TB diagnosis we are involved the develop 3 new rapid test for primary MR and XR TB now New TB Drugs: To ensure that our TB products remains diverse, we proactively recruit the very best talent available in the New drugs TB Research . Perhaps more important, we strive to retain the most knowledgeable and talented team members by encouraging the diversity they bring to the organization. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | January 6, 2016 |
| Last updated: | April 20, 2018 |